
Newer cell separators can collect more PMN, especially using macromolecular agents and steroid stimulation of donors. Proper indications for PMN transfusion are severe neutropenia and sepsis, or certain localized infections, when prolonged marrow aplasia is expected. Optimal dosage is at least 2 x 10(10) PMN per day, probably more. There is a need for more accurate definition of clinical indications for PMN support, for still greater PMN yields from leukapheresis, and for better PMN storage capability.
Blood Specimen Collection, Neutropenia, Macromolecular Substances, Histocompatibility Testing, Anticoagulants, Transfusion Reaction, Blood Donors, Bacterial Infections, Leukocyte Count, Dogs, Adrenal Cortex Hormones, Blood Preservation, Blood Group Incompatibility, Animals, Humans, Blood Transfusion, Clinical Competence, Leukapheresis, Granulocytes
Blood Specimen Collection, Neutropenia, Macromolecular Substances, Histocompatibility Testing, Anticoagulants, Transfusion Reaction, Blood Donors, Bacterial Infections, Leukocyte Count, Dogs, Adrenal Cortex Hormones, Blood Preservation, Blood Group Incompatibility, Animals, Humans, Blood Transfusion, Clinical Competence, Leukapheresis, Granulocytes
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
